Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up.

Hersh CM, Love TE, Bandyopadhyay A, Cohn S, Hara-Cleaver C, Bermel RA, Fox RJ, Cohen JA, Ontaneda D.

Mult Scler J Exp Transl Clin. 2017 Aug 24;3(3):2055217317715485. doi: 10.1177/2055217317715485. eCollection 2017 Jul-Sep.

2.

Wellness and the Role of Comorbidities in Multiple Sclerosis.

Moss BP, Rensel MR, Hersh CM.

Neurotherapeutics. 2017 Oct;14(4):999-1017. doi: 10.1007/s13311-017-0563-6. Review.

PMID:
28785958
3.

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up.

Hersh CM, Love TE, Cohn S, Hara-Cleaver C, Bermel RA, Fox RJ, Cohen JA, Ontaneda D.

Mult Scler Relat Disord. 2016 Nov;10:44-52. doi: 10.1016/j.msard.2016.08.002. Epub 2016 Aug 8.

PMID:
27919497
4.

Optic Neuropathy and Stroke Secondary to Invasive Aspergillus in an Immunocompetent Patient.

Hersh CM, John S, Subei A, Willis MA, Kosmorsky GS, Prayson RA, Bhimraj A.

J Neuroophthalmol. 2016 Dec;36(4):404-407.

PMID:
27031126
5.

Experience with fingolimod in clinical practice.

Hersh CM, Hara-Cleaver C, Rudick RA, Cohen JA, Bermel RA, Ontaneda D.

Int J Neurosci. 2015;125(9):678-85. doi: 10.3109/00207454.2014.969839. Epub 2014 Oct 29.

6.

Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.

Hersh CM, Cohen JA.

Immunotherapy. 2014;6(3):249-59. doi: 10.2217/imt.14.7. Review.

PMID:
24762071
7.

Determination of growth rate depression of some green algae by atrazine.

Hersh CM, Crumpton WG.

Bull Environ Contam Toxicol. 1987 Dec;39(6):1041-8. No abstract available.

PMID:
3440142
8.

Attitudes of College Seniors toward Federal and Industrial Employment.

Hattery LH, Hersh CM.

Science. 1954 Jul 2;120(3105):12-4. No abstract available.

PMID:
17797502

Supplemental Content

Loading ...
Support Center